title: HMOX1 and GST variants modify attenuation of FEF25-75% decline due to PM10 reduction.
abstract: Reduced exposure to particulate matter with a 50% cut-off aerodynamic diameter of 10 microm (PM(10)) attenuated age-related lung function decline in our cohort, particularly in the small airways. We hypothesised that polymorphisms in glutathione S-transferase (GST) and haem oxygenase-1 (HMOX1) genes, important for oxidative stress defence, modify these beneficial effects. A population-based sample of 4,365 adults was followed up after 11 yrs, including questionnaire, spirometry and DNA blood sampling. PM(10) exposure was estimated by dispersion modelling and temporal interpolation. The main effects on annual decline in forced expiratory flow at 25-75% of forced vital capacity (FEF(25-75%)) and interactions with PM(10) reduction were investigated for polymorphisms HMOX1 rs2071746 (T/A), rs735266 (T/A) and rs5995098 (G/C), HMOX1 (GT)(n) promoter repeat, GSTM1 and GSTT1 deletions, and GSTP1 p.Ile105Val, using mixed linear regression models. HMOX1 rs5995098, HMOX1 haplotype TTG and GSTP1 showed significant genetic main effects. Interactions with PM(10) reduction were detected: a 10 microg.m(-3) reduction significantly attenuated annual FEF(25-75%) decline by 15.3 mL.s(-1) only in the absence of HMOX1 haplotype ATC. Similarly, carriers of long (GT)(n) promoter repeat alleles or the GSTP1 Val/Val genotype profited significantly more from a 10 microg.m(-3) reduction (26.5 mL.s(-1) and 27.3 mL.s(-1) respectively) than non-carriers. Benefits of a reduction in PM(10) exposure are not equally distributed across the population but are modified by the individual genetic make-up determining oxidative stress defence.
authors.affiliation: Chronic Disease Epidemiology, Institute of Social and Preventive Medicine, University of Zürich.
authors.forename: I
authors.initials: I
authors.lastname: Curjuric
authors.forename: M
authors.initials: M
authors.lastname: Imboden
authors.forename: C
authors.initials: C
authors.lastname: Schindler
authors.forename: S H
authors.initials: SH
authors.lastname: Downs
authors.forename: M
authors.initials: M
authors.lastname: Hersberger
authors.forename: S L J
authors.initials: SL
authors.lastname: Liu
authors.forename: G
authors.initials: G
authors.lastname: Matyas
authors.forename: E W
authors.initials: EW
authors.lastname: Russi
authors.forename: J
authors.initials: J
authors.lastname: Schwartz
authors.forename: G A
authors.initials: GA
authors.lastname: Thun
authors.forename: D S
authors.initials: DS
authors.lastname: Postma
authors.forename: T
authors.initials: T
authors.lastname: Rochat
authors.forename: N M
authors.initials: NM
authors.lastname: Probst-Hensch
mesh_terms: D000328:Adult; D000368:Aged; D056151:Airway Remodeling / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D051549:Glutathione S-Transferase pi / Q000235:genetics*; D005982:Glutathione Transferase / Q000235:genetics; D006239:Haplotypes; D051547:Heme Oxygenase-1 / Q000235:genetics*; D006801:Humans; D008297:Male; D008450:Maximal Midexpiratory Flow Rate; D008875:Middle Aged; D052638:Particulate Matter / Q000009:adverse effects*; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic
chemical_list: D051549:Glutathione S-Transferase pi; D005982:Glutathione Transferase; D051547:Heme Oxygenase-1; D052638:Particulate Matter; C413545:glutathione S-transferase T1